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OBJECTIVE — Type 1 diabetes is associated with a wide spectrum of susceptibility and
protective genotypes within the HLA class II system. It has been reported that adults diagnosed
with youth-onset type 1 diabetes more recently have been found to have fewer classical high-risk
HLA class II genotypes than those diagnosed several decades ago. We hypothesized that such
temporal trends in the distribution of HLA-DR, DQ genotypes would be evident, and perhaps
even stronger, among 5- to 17-year-old Hispanic and non-Hispanic white (NHW) youth diag-
nosed with type 1 diabetes in Colorado between 1978 and 2004.
RESEARCH DESIGN AND METHODS — HLA-DR, DQ was typed using PCR and
sequence-specific oligonucleotide hybridization in 100 youth diagnosed during the period of
1978–1988 and 264 diagnosed during 2002–2004. Logistic regression was used to adjust for
confounders and assess temporal trends.
RESULTS — The frequency of the highest-risk genotype (DRB1*03-DQB1*02/DRB1*04-
DQB1*03) was higher (39%) in children diagnosed during the period 1978–1988 than in those
diagnosed during 2002–2004 (28%). A similar pattern was observed in NHWs and Hispanics.
CONCLUSIONS — We found that high-risk HLA genotypes are becoming less frequent over
time in youth with type 1 diabetes of NHW and Hispanic origin. This temporal trend may suggest
that increasing environmental exposure is now able to trigger type 1 diabetes in subjects who are
less genetically susceptible.
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The incidence of type 1 diabetes inyouth under 20 years of age is in-creasing worldwide (1). Recently,
we reported an annual average increase of
2.3% in youth 0–17 years of age in Colo-
rado, with the greatest increase reported
in children under 5 years of age (2).
Trends of such magnitude and consis-
tency can only be explained by changes in
environmental risk factors (3). Recent hy-
potheses argue that an increased environ-
mental pressure associated with type 1
diabetes risk may reduce the need for a
strong background of genetic susceptibil-
ity in order for type 1 diabetes to develop.
Type 1 diabetes has a genetic com-
ponent that is neither sufficient nor nec-
essary, in terms of current known
determinants. HLA class II region poly-
morphisms alone explain 40 –50% of fa-
milial clustering in type 1 diabetes risk
(4). There is an approximate 5-fold in-
crease in risk of type 1 diabetes for the
homozygous expression of either
DRB1*03 or DRB1*04 and a 14-fold in-
creased risk for those with heterozygous
expression (DRB1*03/DRB1*04) (5).
Although the DRB1 and the DQA1 and
DQB1 genes are important in determin-
ing susceptibility to type 1 diabetes, ex-
amining the penetrance of these genes
has provided a better understanding of
the involvement of environmental risk
factors. Four studies (6 –9) have ex-
plored potential temporal changes in
the frequency and/or distribution of
HLA genotypes associated with type 1
diabetes susceptibility. All have sug-
gested a decreasing frequency of high-
risk HLA genotypes over time in adults
diagnosed with childhood-onset type 1
diabetes. A study conducted in the U.K.
reported a 12% decrease in the fre-
quency of the high-risk HLA genotype
(DRB1 03-DQA1*0501-DQB1*0201/
DRB1 04-DQA1*0301-DQB1*0302)
between individuals diagnosed recently
compared with 50 years ago (8). A sim-
ilar decrease in the frequency of the
high-risk HLA genotype (7.1% over a
62-year time period) was noted in Fin-
land (9). These studies, however, were
all performed among surviving adults
with childhood-onset type 1 diabetes
and thus may have been biased by
changes in mortality rates among peo-
ple with type 1 diabetes over the last 50
years, especially if mortality was associ-
ated with specific HLA genotypes. Fur-
ther studies, which are not limited to
adult survivors and capture younger in-
dividuals close to the time of diagnosis,
are needed to address the question of
changes in type 1 diabetes–related HLA
genotypes over time.
The purpose of this report was to de-
termine potential temporal trends in the
frequency distribution of HLA suscepti-
bility genes (HLA-DR and HLA-DQ geno-
types) among 5- to 17-year-old Hispanic
and non-Hispanic white (NHW) youth
with type 1 diabetes from Colorado,
newly diagnosed with diabetes between
1978 and 2004.
RESEARCH DESIGN AND
METHODS — Subjects included in
this study were identified through two
different diabetes registry studies con-
ducted 13 years apart: the Colorado Type
1 Diabetes Registry and the Colorado Site
of the SEARCH for Diabetes in Youth
Study. The Colorado Type 1 Diabetes
Registry was a statewide registry devel-
oped to ascertain all new cases of type 1
diabetes in 0- to 17-year-olds in Colorado
● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
From the 1University of Colorado Denver, School of Medicine, Denver, Colorado; and the 2Barbara Davis
Center, Aurora, Colorado.
Corresponding author: Kendra Vehik, kendra.vehik@uchsc.edu.
Received 21 November 2007 and accepted 18 March 2008.
Published ahead of print at http://care.diabetesjournals.org on 20 March 2008. DOI: 10.2337/dc07-2210.
© 2008 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
P a t h o p h y s i o l o g y / C o m p l i c a t i o n s
O R I G I N A L A R T I C L E
1392 DIABETES CARE, VOLUME 31, NUMBER 7, JULY 2008
from 1 January 1978 to 31 December
1988 (10,11). SEARCH is a multicenter,
population-based observational registry
that ascertained new cases of physician-
diagnosed diabetes in youth 0–19 years
of age from 1 January 2002 forward (12).
A detailed description of this population
(2), the Colorado Type 1 Diabetes Regis-
try (10,11), and SEARCH have been pub-
lished (12). Type 1 diabetes was defined
as use of insulin within 2 weeks from di-
agnosis. Completeness of case ascertain-
ment was assessed by the capture-
recapture method (13,14) and estimated
to be 96–97% over time (2).
Youth aged 5–17 years identified with
incident type 1 diabetes during the period
of 1978–1988 and 2002–2004 were eli-
gible to participate in this analysis. In
1978–1988, all Hispanic youth (n  120)
and a similar size random sample of NHW
(n  122) youth identified by the Colo-
rado Type 1 Diabetes Registry were eligi-
ble for genetic typing, and 41 Hispanic
(34%) and 59 NHW youth (48%) had
HLA measured (15). In 2002–2004, all
youth over the age of 4 years of Hispanic
(n  87) or NHW (n  512) origin were
eligible for genetic typing. A total of 39
Hispanic (45%) and 225 NHW (44%)
youth participated. Age at diagnosis, sex,
and family history of diabetes were as-
sessed to determine whether the youth
with HLA measured were representative
of the overall registered population in
each period and racial/ethnic group.
Date of diagnosis and date of birth
were obtained from medical records.
Family history of diabetes was obtained
from medical record abstraction (71% in
1978–1988 and 85% in 2002–2004) or
from self-administered questionnaires
completed within 5 years from the date of
diagnosis (17% in 1978–1988 and 3% in
2002–2004). Children who had a sibling,
parent, or grandparent with any type of
diabetes were defined as having a positive
family history.
To assess whether the sample of
youth with available HLA typing was rep-
resentative of the entire patient popula-
tion of youth with type 1 diabetes
diagnosed in these two time periods, de-
mographic and clinical characteristics of
study participants were compared with
those of nonparticipants. Table 1 shows
these characteristics according to time pe-
riod and ethnicity. In 1978–1988, there
were no significant differences for either
NHW or Hispanic youth. In 2002–2004,
the only significant difference between
those with and without HLA typing was a
higher frequency of a positive family his-
tory of diabetes in NHW participants with
typing available. However, no significant
relationship was noted between having
the h ighes t - r i sk HLA geno type
( D R B 1 * 0 3 - D Q B 1 * 0 2 / D R B 1 * 0 4 -
DQB1*03) and having a positive family
history of diabetes in either time period
(P  0.96). These data suggest that our
samples of NHW and Hispanic youth
with measured HLA are likely representa-
tive of the larger eligible population with
type 1 diabetes in both periods, or that
they differ in characteristics not strongly
related with the frequency of high-risk
HLA genotypes. Therefore, we believe
that any observed trends or lack thereof in
the frequency and distribution of HLA ge-
notypes over time in our population are
not likely to be due to selection bias. All
participants provided informed consent
and both the Colorado Type 1 Diabetes
Registry and SEARCH were approved by
relevant institutional review boards.
HLA typing
DRB1 and DQB1 typing was performed
using OneLambda PCR assays that were
standard for the time period in which they
were used (1978–1988 and 2002–2004)
(16). The main difference between assays
was the number of DQB1 alleles identified
that had sequence-specific oligonucleo-
tides (SSOs) available for typing. There
were seven DQB1 SSOs identified for typ-
ing in 1978–1988, and there were 100
DQB1 SSOs identified for typing in 2002–
2004. Due to the difference in the number
of DQB1 alleles identified and the avail-
ability of SSOs for typing these alleles over
the two periods, only the gene locus was
used in the analysis to compare genotypes
(e.g., DQB1*02 vs. DQB1*0201). Addi-
tionally, the current PCR sequence–
specific oligonucleotide probes used in
2002–2004 allowed for a larger number
Table 1—Characteristics of the study population by time period (1978–1988 and 2002–2004) and participation status in the HLA typing
NHW Hispanic
Nonparticipants Participants P Nonparticipants Participants P
1978–1988
n 58 59 122 75 41 120
Sex (%male/%female) 54/46 45/55 0.17 37/63 41/59 0.66
Family history (%yes/%no) 54/46 44/56 0.15 55/45 69/31 0.16
Age-group at diagnosis (years)
5–9 38 (22) 41 (24) 28 (21) 32 (13)
10–14 48 (28) 42 (25) 0.64 52 (39) 57 (23) 0.42
15–17 14 (8) 17 (10) 20 (15) 11 (5)
Mean age at diagnosis (years) 11.2  3.3 11.1  3.4 0.73 11.8  3.1 11.2  3.0 0.27
2002–2004
n 287 225 512 48 39 87
Sex (%male/%female) 53/47 53/47 0.95 56/44 49/51 0.48
Family history (%yes/%no) 48/52 58/42 0.04 59/41 69/31 0.32
Age-group at diagnosis (years)
5–9 38 (109) 38 (86) 40 (19) 36 (14)
10–14 46 (132) 48 (108) 0.76 52 (25) 49 (19) 0.59
15–17 16 (46) 15 (31) 8 (4) 13 (6)
Mean age at diagnosis (years) 11.2  3.4 10.5  3.4 0.39 10.8  3.0 11.5  4.4 0.32
Data are % (n) and means  SD unless otherwise indicated.
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of samples to be typed at one time com-
pared with the prior assay (17,18). Previ-
ous va l idat ion studies based on
OneLambda Luminex SSO typing yielded
similar results when compared with the
earlier SSO assay (19).
Genotypes assessed in both time pe-
riods were categorized as high risk
( D R B 1 * 0 3 - D Q B 1 * 0 2 / D R B 1 * 0 4 -
DQB1*03); moderate to low risk
( D R B 1 * 0 4 - D Q B 1 * 0 3 / D R B 1 * 0 4 -
DQB1*03, DRB1*04-DQB1*03/X,
where X is not DRB1*03-DQB1*02, and
DRB1*04-DQB1*03/unknown); low risk
( D R B 1 * 0 3 - D Q B 1 * 0 2 / D R B 1 * 0 3 -
DQB1*02, DRB1*03-DQB1*02/X,
where X is not DRB1*04-DQB1*03, and
DRB1*03-DQB1*02/unknown); and
neutral risk (X/X or X/unknown). The X
haplotype denotes all other haplotypes
not defined above. The unknown haplo-
type denotes a haplotype that was unable
to be typed.
Statistical analyses
Descriptive univariate analysis was used
to determine the frequency of the geno-
types for each period. 2 statistics were
used to compare frequencies of HLA hap-
lotypes by race and period and genotypes
by high-risk (DRB1*03-DQB1*02/
DRB1*04-DQB1*03) versus all other ge-
notypes. Multivariate logistic regression
was used to adjust for potential con-
founders (onset age, sex, family history of
diabetes, and race/ethnicity) and assess
temporal trends. High-risk was compared
with all other genotypes using all other
genotypes as the referent group. SAS ver-
sion 9.1 (20) was used for all analyses.
RESULTS — A total of 364 youth (100
in 1978–1988, and 264 in 2002–2004)
with new-onset type 1 diabetes at age
5–17 years had HLA genes measured as
described above.
Table 2 shows the frequency of HLA
class II DRB1-DQB1 genotypes by time
period and ethnicity. More children (both
NHW and Hispanic) carried the high-risk
genotype (DRB1*03-DQB1*02/DR04-
DQB1*03) in 1978–1988 than in 2002–
2004 (P  0.05). Conversely, more
children in 2002–2004 carried the mod-
erate to low risk DRB1*04-DQB1*03
(homo- or heterozygous) genotypes than
in 1978–1988 (P  0.04). There was no
significant difference by time period or
ethnicity in frequency of the neutral risk,
DRB1*03-DQB1*02 (homo- or heterozy-
gous), or X/X genotypes. These patterns
were similar for NHW and Hispanic
youth with type 1 diabetes.
Using multiple logistic regression
analysis (Table 2), we assessed the associ-
ation between having the high-risk geno-
type (versus all other genotypes) and time
period, controlling for age, sex, race/
ethnicity, and family history of diabetes.
There was a 40% lower odds for carrying
the high-risk genotype in 2002–2004 ver-
sus 1978–1988 (odds ratio 0.60 [95% CI
0.36 – 0.99], P  0.05). A decreasing
trend over the two time periods was noted
for both NHWs (13%) and Hispanics
(6%). Conversely, there was a 70%
greater chance of carrying the moderate-
to low-risk genotypes in 2002–2004 ver-
sus 1978 –1988 (1.7 [1.1–2.8], P 
0.03). No significant interactions be-
tween ethnicity and time period on the
odds of having the highest risk genotype
were noted. When stratified according to
age-group (Table 3), the most dramatic
decreasing trend in the prevalence of the
high-risk genotype occurred in those
aged 5–9 years (51% [1978–1988] vs.
32% [2002–2004], P  0.05) with a co-
incident increasing trend in the propor-
tion with the DRB1*04-DQB1*03
(homo- or heterozygous) genotype in the
same age-group (19% [1978–1988] to
40% [2002–2004], P  0.03). No signif-
icant differences over time were noted in
the other age-groups.
CONCLUSIONS — We found that
the distribution of HLA genotype
changed in youth with type 1 diabetes di-
agnosed 27 years apart. Having type 1 di-
abetes at age 5–17 years in 2002–2004
was associated with an 11% difference or
0.6-fold lower odds for carrying the high-
risk HLA genotype (DRB1*03-DQB1*02/
DRB1*04-DQB1*03) compared with
having type 1 diabetes in 1978–1988.
The largest proportional difference (19%)
over time in the high-risk genotype was
Table 2—Distribution of HLA class II genotypes (DRB1-DQB1) and odds ratios (ORs) for the association between genotype and period
(1978–1988 vs. 2002–2004), according to participants’ ethnicities
NHW Hispanic All
n (%) OR (95% CI)* n (%) OR (95% CI)* n (%) OR (95% CI)*
DRB1*03-DQB1*02/DRB1*04-DQB1*03
1978–1988 24 (41) 15 (37) 39 (39)




1978–1988 18 (31) 12 (29) 30 (30)




1978–1988 12 (20) 8 (19) 20 (20)
2002–2004 50 (22) 1.1 (0.6–2.3) 5 (13) 0.6 (0.2–2.0) 55 (21) 1.1 (0.6–1.9)
X/X, X/unknown
1978–1988 5 (8) 6 (15) 11 (11)
2002–2004 16 (7) 0.8 (0.3–2.4) 7 (18) 1.3 (0.4–4.2) 23 (8.7) 0.8 (0.4–1.6)
*OR for the association between period 2002–2004 versus 1978–1988 and carrying the high-risk genotype compared with all other genotypes. †DRB1*03-
DQB1*02/DRB1*04-DQB1*03 not included. Data in bold are statistically significant.
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found in 5- to 9-year-olds, suggesting that
environmental pressures may have a
greater impact on type 1 diabetes risk at
earlier ages. This is the first documenta-
tion of such a trend in a representative
biracial sample of youth with type 1 dia-
betes in the U.S.
Our study supports previous findings
from Finland (9) and the U.K (8), both
including Caucasian adults with child-
hood-onset type 1 diabetes diagnosed up
to 80 years apart. The U.K. study showed
that the frequency of the high-risk geno-
type was 12% lower in adults diagnosed
up to 15 years of age in 1985–2002 com-
pared with those diagnosed between
1922–1946 and 21% lower in those diag-
nosed under 5 years of age (8). The Finn-
ish study showed that the frequency of the
high-risk genotype was 7.1% lower and
that of protective genotypes was 7.2%
higher in adults with childhood-onset
type 1 diabetes diagnosed after 1990
compared with those diagnosed before
1965 (9). Two older studies conducted in
Finland in the 1980s reported a decrease
in HLA-DR3 by 25% for those diagnosed
with type 1 diabetes in the 1980s com-
pared with those diagnosed in the 1960s
(6,7). However, the major limitation of
these studies was the potential for selec-
tion bias. Neither of these studies pro-
vided information on the size or
representativeness of the referent popula-
tion. More importantly, two studies (8,9)
measured HLA in adults who were diag-
nosed with type 1 diabetes as children in
the first half of the 20th century, when
early mortality associated with type 1 di-
abetes was high. Therefore, the frequency
and distribution of HLA genotypes in this
sample may be significantly influenced by
factors associated with survival of type 1
diabetes. An underestimate of the propor-
tional distribution of high-risk HLA geno-
types in earlier time periods (due to a
potential association of high-risk HLA
genes with increased mortality) may have
resulted in underestimating the true tem-
poral trends in the proportion of type 1
diabetes cases with high-risk HLA geno-
types in these earlier studies. In contrast,
our study genotyped youth with type 1
diabetes relatively close to their disease
onset and thus is not affected by survivor
bias. In addition, we were able to provide
evidence that the sample included in the
analysis was representative of the Colo-
rado population of youth with type 1 di-
abetes in both time periods.
Nevertheless, our study has several
limitations. Importantly, although the
same method was used for typing, due to
the specific time periods in which they
were performed, two slightly different as-
says were used, namely, OneLambda Lab-
Type Luminex SSO in 2002–2004 and
OneLambda SSO in 1978 –1988. We
were unable to validate the results ob-
tained with the earlier SSO assay due to
the lack of stored DNA samples and in-
ability to recontact participants. How-
ever, previous studies (19,21) suggest
comparable agreement in serologic spec-
ificity with an 85% allele agreement. Due
to this and the difference in the number of
allele SSOs available for typing over time,
only the gene locus was used in this anal-
ysis. By not using expanded allele infor-
mation, we potentially introduced some
misclassification, likely increasing the
proportion with the high-risk genotype.
However, misclassification would be sim-
ilar for both time periods and therefore
unlikely to influence our analysis of
trends. Because for 2002–2004 we did
have allele information on 100 DQB1
SSOs, we estimated the magnitude of the
potential misclassification, and only four
(1.5%) cases were misclassified as having
the highest-risk genotype in 2002–2004
using the expanded allele information
only. In addition, there were 12 youth
from 1978–1988 that did not have com-
plete genotypes. These youth were in-
cluded in the study and classified as
haplotype unknown. This categorization
could have led to some misclassification.
Specifically, if the unknown haplotype
was DRB1*03-DQB1*02 or DRB1*04-
DQB1*03, youth would have been classi-
fied as high risk based on the typed
haplotype or as heterozygous for the
above haplotypes. For example, in the ex-
treme situation where all youth with the
unknown haplotype in the first time pe-
riod would have been in fact at “high-
risk,” the proportion of youth with the
Table 3—Distribution of HLA class II genotypes (DRB1-DQB1) and odds ratios (ORs) for the association between genotype and period
(1978–1988 vs. 2002–2004) by age-group at diagnosis
5–9 years of age 10–14 years of age 15–17 years of age
n (%) OR (95% CI)* n (%) OR (95% CI)* n (%) OR (95% CI)*
DRB1*03-DQB1*02/DRB1*04-DQB1*03
1978–1988 19 (51) 14 (29) 6 (40)




1978–1988 7 (19) 20 (42) 3 (20)




1978–1988 7 (19) 9 (19) 4 (27)
2002–2004 20 (20) 1.1 (0.4–2.8) 28 (22) 1.2 (0.5–2.8) 7 (19) 0.6 (0.6–2.6)
X/X, X/unknown
1978–1988 4 (11) 5 (10) 2 (13)
2002–2004 7 (8) 0.6 (0.2–2.3) 11 (8) 0.8 (0.3–2.5) 5 (14) 1.0 (0.2–5.9)
*OR for the association between period 2002–2004 versus 1978–1988 and carrying the high-risk genotype compared with all other genotypes. †DRB1*03-
DQB1*02/DRB1*04-DQB1*03 not included. Data in bold are statistically significant.
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highest risk genotype in 1978 –1988
would have been 51% (instead of 39%).
This would have made our trend esti-
mates even more substantial (i.e., a 23%
decrease in the proportion with high-risk
genotype). Consequently, our estimated
change of 11% is conservative.
There are several hypotheses proposed
to explain the increase in type 1 diabetes
incidence in youth and the earlier age at on-
set. The “accelerator” and “overload” hy-
potheses suggest that an increase in body
mass in genetically susceptible individuals
accelerates -cell decline or stresses (over-
loads) the -cells, leading to an early age at
type 1 diabetes diagnosis (22,23). The “hy-
giene hypothesis” postulates that the de-
creasing early life exposure to infectious
agents in Westernized societies has led to an
impairment in the maturation of the im-
mune system, thus permitting an increased
occurrence of immune-mediated disorders,
such as asthma and type 1 diabetes (24).
Further testing is required for all of these
hypotheses.
Given that there is an increasing inci-
dence of type 1 diabetes in Colorado youth
(2), our findings support the hypothesis
that environmental pressures may be in-
creasing the disease penetrance despite a
shift in the distribution of HLA genotypes
from high to moderate-low risk. Although
this and previous studies (6–9) evaluating
the distribution and frequency of HLA sus-
ceptibility genes over time have provided
evidence in support of this hypothesis, the
nature of environmental factors responsible
for the increasing incidence of type 1 diabe-
tes remains unknown.
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